Hana Golan

770 total citations
32 papers, 405 citations indexed

About

Hana Golan is a scholar working on Immunology, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Hana Golan has authored 32 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Hematology. Recurrent topics in Hana Golan's work include Immunodeficiency and Autoimmune Disorders (7 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Ethics and Legal Issues in Pediatric Healthcare (5 papers). Hana Golan is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (7 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Ethics and Legal Issues in Pediatric Healthcare (5 papers). Hana Golan collaborates with scholars based in Israel, United States and Canada. Hana Golan's co-authors include Amos Toren, Gideon Rechavi, Bella Bielorai, Ninette Amariglio, Yoram Neumann, Sara Pri‐Chen, Ginette Schiby, Tamar Fisher, Baruch Wolach and Paula Feder‐Bubis and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Nutrients and Pediatric Research.

In The Last Decade

Hana Golan

30 papers receiving 395 citations

Peers

Hana Golan
Simon Cronin United States
J. Keith Pinckard United States
Vanesa Hauk Argentina
S. Atmani Morocco
S. Ohlman Sweden
R. M. Goldblum United States
Simon Cronin United States
Hana Golan
Citations per year, relative to Hana Golan Hana Golan (= 1×) peers Simon Cronin

Countries citing papers authored by Hana Golan

Since Specialization
Citations

This map shows the geographic impact of Hana Golan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hana Golan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hana Golan more than expected).

Fields of papers citing papers by Hana Golan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hana Golan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hana Golan. The network helps show where Hana Golan may publish in the future.

Co-authorship network of co-authors of Hana Golan

This figure shows the co-authorship network connecting the top 25 collaborators of Hana Golan. A scholar is included among the top collaborators of Hana Golan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hana Golan. Hana Golan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Vax, Einav, Rachel Shukrun, Naomi Pode‐Shakked, et al.. (2025). A novel Frizzled 7 antibody disrupts the Wnt pathway and inhibits Wilms tumor growth. Frontiers in Bioengineering and Biotechnology. 13. 1641137–1641137. 1 indexed citations
3.
Lev, Atar, Anthony Simon, Shirly Frizinsky, et al.. (2025). Outcome of hematopoietic stem cell transplantation for severe combined immunodeficiency and impact of newborn screening on overall survival: A single referral center study. Journal of Allergy and Clinical Immunology. 155(6). 1800–1812.
4.
Abebe‐Campino, Gadi, Hana Golan, Asaf Vivante, et al.. (2023). Insights Image for “Treatment of severe Kaposiform Lymphangiomatosis positive for NRAS mutation by MEK-inhibition”. Pediatric Research. 94(6). 2117–2117. 2 indexed citations
5.
Abebe‐Campino, Gadi, Hana Golan, Asaf Vivante, et al.. (2022). Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition. Pediatric Research. 94(6). 1911–1915. 28 indexed citations
6.
Freund, Tal, Sarah K. Baxter, Tom Walsh, et al.. (2022). Clinically Complex LRBA Deficiency Due to a Founder Allele in the Georgian Jewish Population. Journal of Clinical Immunology. 43(1). 151–164. 1 indexed citations
7.
Granek, Leeat, et al.. (2021). Oncologist conceptualizations of pediatric palliative care: challenges and definitions. Supportive Care in Cancer. 29(7). 3981–3989. 10 indexed citations
8.
Shukrun, Rachel, Hana Golan, Naomi Pode‐Shakked, et al.. (2019). NCAM1/FGF module serves as a putative pleuropulmonary blastoma therapeutic target. Oncogenesis. 8(9). 48–48. 6 indexed citations
9.
Bielorai, Bella, Moshe Leitner, Gal Goldstein, et al.. (2019). Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a <b><i>CCDC88C-PDGFRB</i></b> Fusion Gene. Acta Haematologica. 141(2). 119–127. 7 indexed citations
10.
Golan, Hana, Rachel Shukrun, Einav Vax, et al.. (2018). In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example. Stem Cell Reports. 11(3). 795–810. 25 indexed citations
11.
Fisher, Tamar, Hana Golan, Ginette Schiby, et al.. (2016). In Vitro and In Vivo Efficacy of Non-Psychoactive Cannabidiol in Neuroblastoma. Current Oncology. 23(11). 15–22. 57 indexed citations
12.
Lev, Atar, Luba Trakhtenbrot, Hana Golan, et al.. (2013). Severe Eosinophilia in Children. Journal of Pediatric Hematology/Oncology. 35(4). 303–306. 7 indexed citations
13.
Bielorai, Bella, Claus Meyer, Luba Trakhtenbrot, et al.. (2010). Therapy-related acute myeloid leukemia with t(2;11)(q37;q23) after treatment for osteosarcoma. Cancer Genetics and Cytogenetics. 203(2). 288–291. 5 indexed citations
14.
Golan, Hana, et al.. (2008). Integration of a palliative and terminal care center into a comprehensive pediatric oncology department. Pediatric Blood & Cancer. 50(5). 949–955. 23 indexed citations
15.
Tabori, Uri, Ninette Amariglio, Amos Etzioni, et al.. (2004). Detection of RAG mutations and prenatal diagnosis in families presenting with either T–B– severe combined immunodeficiency or Omenn's syndrome. Clinical Genetics. 65(4). 322–326. 30 indexed citations
16.
Bielorai, Bella, L. Trakhtenbrot, Ninette Amariglio, et al.. (2004). Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients. Bone Marrow Transplantation. 34(4). 317–320. 11 indexed citations
17.
Bielorai, Bella, Hana Golan, Luba Trakhtenbrot, et al.. (2002). Combined analysis of morphology and fluorescence in situ hybridization in follow-up of minimal residual disease in a child with Philadelphia-positive acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 138(1). 64–68. 14 indexed citations
18.
Bielorai, Bella, Yoram Neumann, Itamar Avigad, et al.. (2000). Successful treatment of vancomycin-resistantEnterococcus sepsis in a neutropenic patient with G-CSF-mobilized granulocyte transfusions. Medical and Pediatric Oncology. 34(3). 221–223. 4 indexed citations
19.
Toren, Amos, Arnon Nagler, Ninette Amariglio, et al.. (1999). Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency. Bone Marrow Transplantation. 23(4). 405–408. 10 indexed citations
20.
Gurevitch, Jacob, et al.. (1993). D‐Lactic acidosis: a treatable encephalopathy in pediatric patients. Acta Paediatrica. 82(1). 119–121. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026